© 2016-2019 Global Pharma Labs, Inc.

globalpharmalabs@yahoo.com

Toll Free:  1-844-377-5953

 Subscription Agreement
 Global Pharma Labs, Inc.
click here =>
1.  Investment:

       (a.)  The undersigned (“Buyer”) subscribes for ___________________________ Shares of  

              Common Stock of Global Pharma Labs, Inc., (the “Company”) at $1.00 per share.

       (b.)  Total subscription price ($1.00 x Number of Shares): = $ ________________________

              PLEASE MAKE CHECKS PAYABLE TO:  GLOBAL PHARMA LABS, INC.

 

2.  Investor Information:

         Name (type or print)                                            SSN/EIN/Taxpayer I.D.

 

              __________________________________________         ____________________________________

 

              E-mail address:  ______________________________________________________________

              Address: ______________________________________________________________________

         

         Joint Name (type or print)                                  SSN/EIN/Taxpayer I.D.

               _________________________________________        ____________________________________

              E-mail address:  _______________________________________________________________

              Address: ______________________________________________________________________

        

         Mailing Address (if different from above:

           

        _______________________________________________________________________

         Business Phone:                                              Home Phone:

                           (          )  _____________________                  (           )  _____________________

3.  Type of Ownership: (You must check one box)

          (    )  Individual                             (    )  Custodian for:  _________________

          (    )  Tenants in Common          (    )  Uniform Gifts to Minors Act of the State of: ___________

                                                                        Corporation (Inc., LLC, LP) Please List all officers, 

                                                                        directors, partners, managers, etc.:

          (    )  Joint Tenants with Rights of Survivorship

          (    )  Partnership (Limited Partnerships use “Corporation”)  

          (    )  Trust

          (    )  Community Property

          (    )  Other (please explain): _____________________________________________________

 

4.  Representations and Warranties of Buyer.

     Buyer hereby represents, warrants, covenants and agrees as follows:

 

   a.  Buyer is at least eighteen (18) years of age with an address as set forth in this

        Subscription Agreement.

   b.  Buyer is under no legal disability nor is Buyer subject to any order, which would prevent

         or interfere with Buyer’s execution, delivery and performance of this Subscription

         Agreement or his or her purchase of the Shares.  The Shares are being purchased solely

         for Buyer’s own account and not for the account of others and for investment purposes

         only, and are not being purchased with a view to or for the transfer, assignment, resale

         or distribution thereof, in whole or part.  Buyer has no present plans to enter into any

         contract, undertaking, agreement or arrangement with respect to the transfer,

         assignment, resale or distribution of any of the Shares.

 

   c.  Buyer has (i) adequate means of providing for his or her current financial needs and

        possible personal contingencies, and no present need for liquidity of the investment in

        the Shares, and (ii) a liquid net worth (that is, ne worth exclusive of a primary residence,

        the furniture and furnishings thereof, and automobiles) which is sufficient to enable

        Buyer to hold the Shares indefinitely.

 

   d.  If the Buyer is acting without a Purchaser Representative, Buyer has such knowledge and

        experience in financial and business matters that Buyer is fully capable of evaluating the

        risks of an investment in the Offering.

   e.  Buyer understands that Buyer shall be required to bear all personal expenses incurred in

        connection with his or her purchase of the Shares, including without limitation, any fees

        which may be payable to any accountants, attorneys or any other persons consulted by

        Buyer in connection with his or her investment in the Offering.

   f.  Buyer acknowledges that the Company’s offering circular, (“Offering Circular”) is the legal

       document filed with the Securities and Exchange Commission, (“SEC”) for a Regulation A

       offering and provides facts that a Buyer needs to make an informed investment decision. 

       The Offering Circular includes an overview of the Company and Company’s business,

       historical financials and capitalization, and key risk factors.  The Offering Circular is made

       available to the general public in the Company’s Form 1-A registration statement initially

       filed on December 14, 2016 and subsequently amended January 26, 2017 and deemed   

       qualified by the SEC on February 13, 2017.

   g.  Buyer has received and carefully reviewed the Offering Circular in its entirety including all

        made available on the SEC Edgar Database by searching the Company name or the

        Company’s CIK number 0001690824.  The Company provided the Buyer with the following

        internet hyperlink to its registration statement and Offering Circular for convenience.

       

       https://www.sec.gov/Archives/edgar/data/1690824/000169082417000007/globalpharma_a1.htm 

 

5.  Electronic Delivery of Documents (Buyer will not receive paper mailings).

     In lieu of receiving documents by mail, Buyer authorizes the Company to make available on

     the SEC EDGAR DATA BASE website at: https://www.sec.gov/search/search.htm its offering

     circular, amendments to the offering circular, semi-annual reports, annual reports, tender

     offer materials, proxy statements, prospectus supplements or other reports that may be

     required to be delivered to Buyer.  Buyer must provide an e-mail address below and ensure

     that the Company has a current e-mail address for as long as he or she owns Shares.)

     

          E-mail Address:  ____________________________________________________

 

6.  Acceptance of Subscription

     It is understood that this subscription is not binding upon the Company until accepted by

     the Company, and that the Company has the right to accept or reject this subscription, in

     whole or in part, in its sole and complete discretion.  If this subscription is rejected in whole,

     the Company shall return to Buyer, without interest, the payment tendered by Buyer, in

     which case the Company and Buyer shall have no further obligation to each other

     hereunder.  In the event of a partial rejection of this subscription, Buyer’s Payment will be

     returned to Buyer without interest, whereupon Buyer agrees to deliver a new payment in

     the amount of the purchase price for the number of Share to be purchased hereunder

     following a partial rejection of this subscription.  In the event the subscription is rejected, by

     the Company, the subscriber’s funds shall be fully returned to investor within 5 business

     days.

7.  Governing Law

     This Subscription Agreement shall be governed and construed in all respects in accordance

     with the laws of the State of Delaware without giving effect to any conflict of laws or choice

     of law rules.

8.  CERTIFICATION.

     THE BUYER CERTIFIES THAT HE/SHE HAS READ THIS ENTIRE SUBSCRIPTION AGREEMENT

      AND THAT EVERY STATEMENT MADE BY THE BUYER HEREIN IS TRUE AND COMPLETE.

 

IN WITNESS WHEREOF, this Subscription Agreement has been executed  and delivered by the Buyer and by the Company on the respective dates set forth below.

     Printed Name of Buyer:  ______________________________________ 

     Signature of Buyer:  _________________________       Date: ______________

     Printed Name of Buyer:  _____________________________________ 

     Signature of Buyer:  _________________________       Date: ______________

     Investor’s Subscription Accepted this _____ day of _______________, 2017

     Accepted by:  ______________________________________________

                                                 Sylvester L. Crawford

                          (Chief Executive Officer Global Pharma Labs, Inc.)

UPON RECEIPT OF THE SIGNED ORIGINAL SUBSCRIPTION AGREEMENT AND YOUR CHECK, GLOBAL PHARMA LABS, INC. WILL SEND TO YOU ITS ACCEPTANCE OF YOUR SUBSCRIPTION.  MOUNTAIN SHARE WILL ALSO SEND TO YOU YOUR STOCK CERTIFICATES.

 

                       SEND CHECK AND SIGNED ORIGINAL SUBSCRIPTION AGREEMENT TO:

                                                      Global Pharma Labs, Inc.

                                                      433 Estudillo Avenue, Suite 206

                                                      San Leandro, CA 94577 USA